Related Experiment Video

Updated: Mar 12, 2026

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
10:08

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies

Published on: July 20, 2022

2.5K

The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on

Thomas Opladen1, Elisenda Cortès-Saladelafont2, Mario Mastrangelo3

  • 1Division of Child Neurology and Metabolic Diseases, University Children's Hospital Heidelberg, Germany.

Molecular Genetics and Metabolism Reports
|November 11, 2016
PubMed
Abstract

Keywords:
3-PGDH, 3-phosphoglycerat dehydrogenase3-PGH, 3-phosphoglycerat dehydrogenase3-PSP, 3-phosphoserine phosphatase5-MTHF, 5-methyltetrahydrofolateAADC, aromatic l-amino acid decarboxylaseAR/ADGTPCH, autosomal recessive/dominant GTP-cyclohydrolase deficiencyBH4, tetrahydrobiopterinDAT, dopamine transporterDHFR, dihydrofolate reductase deficiencyDHPR, dihydropteridine reductaseDatabaseDopamineDßH, dopamine β-hydroxylaseFOLR1, folate receptor alphaGABAGABA, gamma aminobutyric acidGlycineGuidelineMAOA, monoamine oxidase ANKH, nonketotic hyperglycinemiaNOS, nitric oxide synthaseNetworkNeurotransmitterPAH, phenylalanine hydroxylasePSAT, phosphoserine aminotransferasePTPS, 6-pyruvoyl-tetrahydropterin synthasePatient registrySR, sepiapterin reductaseSSADH, succinic semialdehyde dehydrogenaseSerineSerotoninTH, tyrosine hydroxylaseTPH, tryptophan hydroxylaseVMAT, vesicular monoamine transporter

More Related Videos

Developing a Rat Model for Bipolar Disorder04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.6K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.6K

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.8K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
3.1K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
14.2K